World's Best Scientists 2026 revealed!
Linda A. DiMeglio

Linda A. DiMeglio

D-Index & Metrics

Medicine

D-Index
76
Citations
24632
World Ranking
18688
National Ranking
9312

Overview

Linda A. DiMeglio is affiliated with Indiana University in the United States and has contributed extensively to the field of medical research, focusing primarily on diabetes and related metabolic disorders. Their body of work encompasses over three hundred publications, with a significant emphasis on endocrinology, genetics, and pediatrics.

Their research primarily addresses key topics including:

  • Diabetes Management and Research
  • Diabetes and associated disorders
  • Pancreatic function and diabetes
  • Diabetes Treatment and Management
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Gestational Diabetes Research and Management
  • Diet and metabolism studies

Linda A. DiMeglio's expertise spans main fields of study such as Medicine and Biochemistry, Genetics and Molecular Biology. Subfields of particular focus include Endocrinology, Diabetes and Metabolism, Genetics, Surgery, Pediatrics, Perinatology and Child Health, and Public Health, Environmental and Occupational Health.

Their frequent publication venues illustrate the core platforms for their research dissemination:

  • Diabetes
  • Diabetes Care
  • Communications Medicine
  • Pediatric Diabetes
  • Journal of the Endocrine Society

Linda A. DiMeglio has collaborated frequently with a number of researchers, including Carmella Evans-Molina, Heba M. Ismail, Stephen E. Gitelman, Ingrid Libman, and Laura M. Jacobsen. These recurring partnerships reflect a networked approach in advancing their research agenda.

Notable recent publications authored or co-authored include:

  • Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals, 2021, Science Translational Medicine
  • 100 years of insulin: celebrating the past, present and future of diabetes therapy, 2021, Nature Medicine
  • ISPAD Clinical Practice Consensus Guidelines 2022: Glycemic targets and glucose monitoring for children, adolescents, and young people with diabetes, 2022, Pediatric Diabetes
  • Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine, 2023, Nature Medicine
  • Effect of Verapamil on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes, 2023, JAMA

These works contribute to understanding diabetes pathophysiology, clinical guidelines for glycemic control, and emerging therapeutic approaches. The topics span clinical trials, consensus guidelines, and translational research aiming to improve patient outcomes.

Best Publications

  • State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018

    Nicole C Foster;Roy W Beck;Kellee M Miller;Mark A Clements

  • Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry

    Kellee M. Miller;Nicole C. Foster;Roy W. Beck;Richard M. Bergenstal

  • Type 1 diabetes.

    Linda A DiMeglio;Carmella Evans-Molina;Richard A Oram

  • An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes

    Kevan C. Herold;Brian N. Bundy;S. Alice Long;Jeffrey A. Bluestone

  • Consensus Statement: Global Consensus Recommendations on Prevention and Management of Nutritional Rickets

    Craig F. Munns;Nick Shaw;Mairead Kiely;Bonny L. Specker

  • Global Consensus Recommendations on Prevention and Management of Nutritional Rickets

    Craig F. Munns;Nick Shaw;Mairead Kiely;Bonny L. Specker

  • ISPAD Clinical Practice Consensus Guidelines 2018: Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes

    Linda A. DiMeglio;Carlo L. Acerini;Ethel Codner;Maria E. Craig

  • Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

    Tihamer Orban;Brian Bundy;Dorothy J Becker;Linda A DiMeglio

  • Most Youth With Type 1 Diabetes in the T1D Exchange Clinic Registry Do Not Meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes Clinical Guidelines

    Jamie R. Wood;Kellee M. Miller;David M. Maahs;Roy W. Beck

  • Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial

    Diane K Wherrett;Brian Bundy;Dorothy J Becker;Linda A DiMeglio

  • Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials.

    Antoinette Moran;Brian Bundy;Dorothy J. Becker;Linda A. DiMeglio

  • Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes.

    Manuela Battaglia;Simi Ahmed;Mark S. Anderson;Mark A. Atkinson

  • Racial-Ethnic Disparities in Management and Outcomes Among Children With Type 1 Diabetes

    Steven M. Willi;Kellee M. Miller;Linda A. DiMeglio;Georgeanna J. Klingensmith

  • Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients

    Mark R. Rigby;Kristina M. Harris;Ashley Pinckney;Linda A. DiMeglio

  • Racial Differences in the Relationship of Glucose Concentrations and Hemoglobin A1c Levels

    Richard M Bergenstal;Robin L Gal;Crystal G Connor;Rose Gubitosi-Klug

  • Height outcome in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency : A meta-analysis

    Erica A. Eugster;Linda A. DiMeglio;James C. Wright;Gary R. Freidenberg

  • Prevalence of Detectable C-peptide According to Age at Diagnosis and Duration of Type 1 Diabetes

    Asa K. Davis;Stephanie N. DuBose;Michael J. Haller;Kellee M. Miller

  • A randomized, controlled study of insulin pump therapy in diabetic preschoolers.

    Linda A. DiMeglio;Tina M. Pottorff;Sheryl R. Boyd

  • Diagnosis and Management of Osteopetrosis: Consensus Guidelines From the Osteopetrosis Working Group.

    Calvin C Wu;Michael J Econs;Linda A DiMeglio;Karl L Insogna

  • Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients

    Mark R. Rigby;Kristina M. Harris;Ashley Pinckney;Linda A. DiMeglio

Frequent Co-Authors

Carla J. Greenbaum
Carla J. Greenbaum Virginia Mason Medical Center
William V. Tamborlane
William V. Tamborlane Yale University
Jay S. Skyler
Jay S. Skyler University of Miami
Desmond A. Schatz
Desmond A. Schatz University of Florida
Jeffrey P. Krischer
Jeffrey P. Krischer University of South Florida
Roy W. Beck
Roy W. Beck University of South Florida
Kevan C. Herold
Kevan C. Herold Yale University
David M. Maahs
David M. Maahs Stanford University
Janice S. Blum
Janice S. Blum Indiana University
Mark A. Atkinson
Mark A. Atkinson University of Florida

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to numerous online degree options that complement or enhance your healthcare career. For those interested in preventative care and wellness, online degrees in nutrition provide the foundation to specialize in dietetics and health promotion.

Looking to move into healthcare leadership roles? The best online mha programs allow you to earn a Master of Healthcare Administration conveniently, preparing you for vital management positions in hospitals and clinics.

For registered nurses aiming to advance academically without intensive on-site requirements, you can consider rn bsn online programs no clinicals, which streamline your journey toward a Bachelor of Science in Nursing.

If you’re focused on reaching the highest level of clinical nursing leadership in the shortest time, accelerated dnp programs offer rigorous, fast-track pathways to a Doctor of Nursing Practice degree.

Each of these online pathways offers flexibility, career advancement, and the opportunity to specialize while balancing existing work or study commitments.

Best Scientists Citing Linda A. DiMeglio

Trending Scientists